Comanche Biopharma

Comanche Biopharma is a clinical-stage biopharmaceutical company based in Concord, Massachusetts, developing investigational siRNA (small interfering RNA) medicines for maternal health. Its lead candidate, CBP-4888, is a subcutaneously administered siRNA therapy targeting sFlt1-mediated preterm preeclampsia, a leading and potentially life-threatening complication of pregnancy. The company's mission is to develop and make globally available the first therapy targeting a root cause of preeclampsia. In April 2025, CBP-4888 received Orphan Drug Designation from the European Medicines Agency. Comanche Biopharma is a portfolio company of GV (Google Ventures). As a therapeutics company it publishes a corporate and scientific web presence rather than a public developer API surface.

Comanche Biopharma is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biopharmaceutical, Biotechnology, and Maternal Health.

Comanche Biopharma’s developer surface includes engineering blog, support, and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyLife SciencesBiopharmaceuticalBiotechnologyMaternal HealthPreeclampsiasiRNA TherapeuticsDrug Development

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.9/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/comanche-biopharma: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

Company 5

The organization behind the API

Website

About

Blog

BlogRSS

LinkedIn

Source (apis.yml)

aid: comanche-biopharma
name: Comanche Biopharma
description: Comanche Biopharma is a clinical-stage biopharmaceutical company based in Concord, Massachusetts, developing
  investigational siRNA (small interfering RNA) medicines for maternal health. Its lead candidate, CBP-4888, is a subcutaneously
  administered siRNA therapy targeting sFlt1-mediated preterm preeclampsia, a leading and potentially life-threatening complication
  of pregnancy. The company's mission is to develop and make globally available the first therapy targeting a root cause of
  preeclampsia. In April 2025, CBP-4888 received Orphan Drug Designation from the European Medicines Agency. Comanche Biopharma
  is a portfolio company of GV (Google Ventures). As a therapeutics company it publishes a corporate and scientific web presence
  rather than a public developer API surface.
url: https://raw.githubusercontent.com/api-evangelist/comanche-biopharma/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://comanchebiopharma.com/wp-content/uploads/2023/07/comanchebiopharma-logo-preeclampsia-treatment-prevention-CBP4888-mikeyoung-scottjohnson-biopharmaceutical-siRNAtherapy.png
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Biopharmaceutical
- Biotechnology
- Maternal Health
- Preeclampsia
- siRNA Therapeutics
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://comanchebiopharma.com
- type: About
  url: https://comanchebiopharma.com/about-us/
- type: Blog
  url: https://comanchebiopharma.com/news-and-events/
- type: BlogRSS
  url: https://comanchebiopharma.com/feed/
- type: Support
  url: https://comanchebiopharma.com/contact-us/
- type: TermsOfService
  url: https://comanchebiopharma.com/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/comanche-biopharma/
- type: DomainSecurity
  url: security/comanche-biopharma-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence